From: Serum magnesium level and cardiac valve calcification in hemodialysis patients
Items | CVC group (n = 68) | Non-CVC group (n = 37) | P value |
---|---|---|---|
Age (years) | 66.5 ± 10.1 | 53.9 ± 15.4 | 0.000* |
Male (%) | 42 (61.7) | 18 (48.6) | 0.194 |
Smoking (%) | 23 (33.8) | 5 (13.5) | 0.025* |
Dialysis duration (months) | 58.3 ± 44.9 | 59.7 ± 46.7 | 0.881 |
DM (%) | 50 (73.5) | 11 (29.7) | 0.000* |
LEAO (%) | 18 (26.4) | 1 (2.7) | 0.003* |
CHD (%) | 43 (63.2) | 13 (35.1) | 0.006* |
CAC (%) | 45 (66.1) | 13 (35.1) | 0.002* |
Combined tumor (%) | 13 (19.1) | 0 (0) | 0.004 |
Kt/v | 1.39 ± 0.28 | 1.41 ± 0.26 | 0.804 |
GFR (ml/min/1.732) | 4.93 ± 1.58 | 4.31 ± 1.12 | 0.040* |
Serum UA(µmol/L) | 449.5 ± 63.2 | 462.6 ± 78.5 | 0.357 |
PTH (ng/L) | 241.8 ± 113.8 | 313.7 ± 203.9 | 0.022* |
ALP (U/L) | 85.2 ± 35.8 | 72.7 ± 24.8 | 0.064 |
Serum Ca (mmol/L) | 2.15 ± 0.13 | 2.23 ± 0.14 | 0.007* |
Serum P (mmol/L) | 1.84 ± 0.40 | 1.98 ± 0.36 | 0.084 |
Serum K (mmol/L) | 4.97 ± 0.53 | 4.97 ± 0.49 | 0.936 |
Serum Mg (mmol/L) | 1.09 ± 0.14 | 1.15 ± 0.12 | 0.025* |
Hb (g/L) | 117.2 ± 10.5 | 117.9 ± 10.5 | 0.750 |
TP (g/L) | 65.7 ± 4.9 | 65.1 ± 4.3 | 0.532 |
Alb (g/L) | 39.7 ± 2.8 | 40.8 ± 2.6 | 0.049* |
Pre-ALb (mg/L) | 310.8 ± 58.1 | 350.6 ± 57.5 | 0.001* |
TC (mmol/L) | 3.69 ± 1.04 | 3.74 ± 1.05 | 0.813 |
TG | 2.12 ± 1.22 | 1.91 ± 1.02 | 0.372 |
LDL-C (mmol/L) | 1.96 ± 0.87 | 1.95 ± 0.82 | 0.947 |
HDL-C (mmol/L) | 0.88 ± 0.26 | 1.03 ± 0.26 | 0.006* |
Drug | |||
Calcium carbonate (%) | 21 (30.9) | 12 (32.4) | 0.870 |
Lanthanum carbonate (%) | 7 (10.3) | 7 (18.9) | 0.214 |
Sevelamer (%) | 27 (39.7) | 16 (43.2) | 0.725 |
Cinacalcet (%) | 9 (13.2) | 11 (29.7) | 0.004* |
Calcitriol or Paricalcitol (%) | 29 (42.6) | 21 (56.7) | 0.167 |